Search clinical trials for: EDTA Ophthalmic Solution 1.3%
Total 1668 results
-
Livionex Inc.Completed
-
Bausch & Lomb IncorporatedCompletedAllergic ConjunctivitisUnited States
-
Sylentis, S.A.CompletedDry Eye DiseaseSpain, Portugal, Italy, Estonia, Germany, Slovakia
-
VivaVision Biotech, IncRecruitingInflammationUnited States
-
Santen Inc.Completed
-
Rigel PharmaceuticalsCompletedKeratoconjunctivitis SiccaUnited States
-
Herantis Pharma Plc.ORA, Inc.CompletedDry Eye SyndromeUnited States
-
Aldeyra Therapeutics, Inc.CompletedDry Eye | Dry Eye SyndromesUnited States
-
Silk Technologies, Ltd.Completed
-
Hanlim Pharm. Co., Ltd.Completed
-
Laboratorios Sophia S.A de C.V.WithdrawnConjunctivitis, BacterialMexico
-
Yuyu Pharma, Inc.Active, not recruiting
-
University of RochesterLivionex IncCompletedCorneal Dystrophy, Band-ShapedUnited States
-
Silk Technologies, Ltd.Completed
-
Seinda Pharmaceutical Guangzhou CorporationCompleted
-
Mitotech, SAORA, Inc.CompletedKeratoconjunctivitis SiccaUnited States
-
D.E.L., LLCUnknown
-
Stealth BioTherapeutics Inc.CompletedFuchs' Corneal Endothelial Dystrophy (FCED)United States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedInflammation and Pain Following Ocular SurgeryUnited States
-
TecnoquimicasRecruitingDry Eye DiseaseColombia
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisUnited States
-
Aldeyra Therapeutics, Inc.Completed
-
Aldeyra Therapeutics, Inc.Completed
-
Mimetogen Pharmaceuticals USA, Inc.CompletedDry Eye SyndromesUnited States
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisUnited States
-
Santen Pharmaceutical Co., Ltd.CompletedPrimary Open Angle Glaucoma | Ocular HypertensionJapan
-
Aldeyra Therapeutics, Inc.RecruitingDry Eye DiseaseCanada
-
Mimetogen Pharmaceuticals USA, Inc.Active, not recruitingDry Eye Syndromes | Dry Eye Disease | Kerato Conjunctivitis SiccaUnited States
-
Aldeyra Therapeutics, Inc.Completed
-
Mimetogen Pharmaceuticals USA, Inc.CompletedDry EyeUnited States
-
Mimetogen Pharmaceuticals USA, Inc.CompletedA Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry EyeKeratoconjunctivitis SiccaUnited States
-
Aldeyra Therapeutics, Inc.CompletedDry Eye SyndromesCanada
-
Rigel PharmaceuticalsCompletedChronic Graft-versus-host DiseaseUnited States
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
Aerie PharmaceuticalsCompletedPrimary Open Angle Glaucoma | Ocular HypertensionJapan
-
ORA, Inc.Palatin Technologies, IncCompletedDry Eye DiseaseUnited States
-
Laboratorios Sophia S.A de C.V.WithdrawnConjunctivitis, Allergic | Seasonal Allergic Conjunctivitis | Ocular Itching | Ocular Allergy | Perennial Allergic ConjunctivitisMexico
-
VivaVision Biotech, IncNot yet recruiting
-
Sylentis, S.A.Completed
-
Santen Pharmaceutical Co., Ltd.Completed
-
Santen Pharmaceutical Asia Pte. Ltd.RecruitingOcular Hypertension | Primary Open-angle Glaucoma | Normal Tension Glaucoma | Glaucoma, SuspectKorea, Republic of
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisCanada
-
Sylentis, S.A.CompletedDry Eye Disease | Sjögren SyndromeUnited States, Spain
-
ORA, Inc.Topivert Pharma LtdCompleted
-
Kyushu UniversityCompletedRetinopathy of PrematurityJapan
-
pH PharmaCompletedNormal Tension GlaucomaKorea, Republic of
-
Aldeyra Therapeutics, Inc.RecruitingDry Eye DiseaseUnited States
-
OcuTerra Therapeutics, Inc.CompletedDiabetic Macular EdemaUnited States
-
Aldeyra Therapeutics, Inc.Completed